Interestingly, a recent report also demonstrated that combined treatment of gentamicin with the MEK1/2 inhibitor PD0325901 (ATR-002 was not investigated in the study) with administration starting on day 5 post-infection reduced pathology and bacterial burdens in a murine model of S. aureus osteomyelitis (39). The gene discussed is MAP2K1; the disease is infection.